Patent · US Active

Organic compositions to treat HSF1-related diseases

US8623838B2 · kind B2 · utility

5Cited by

9References

22Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Jinyun Chen · Shanghai, CN
Gregory Hinkle · Plymouth, US
Satyanarayana Kuchimanchi · Cambridge, US
Stuart Milstein · Cambridge, US
Markus Warmuth · Natick, US
Wenlai Zhou · Cambridge, US
Ping Zhu · Boxborough, US
Tracy Zimmermann · Cambridge, US

Key dates

Filing date	Feb 1, 2012
Grant date	Jan 7, 2014
Priority date	—
Expiry date	Feb 1, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.